Vault-13

Knoll Capital Management, LLC

MIAMI, FL · CIK 1325083 · 13F filing filed 2024-08-14

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$148.4m reported value -7.7% vs Q1 2024
35positions
74.0%in top 10
1 new 2 added 0 reduced 0 sold out vs Q1 2024

Holdings, Q2 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 APPLIED THERAPEUTICS INC COM APLT APLT 5,574,687 $26.0m17.54% 17.54% UnchangedShares held: Q3 2023 5.2m, Q4 2023 5.5m, Q1 2024 5.6m, Q2 2024 5.6m
2 BIOHAVEN PHARMACTL HLDG CO L COM BHVN BHVN 710,422 $24.7m16.62% 16.62% AddedShares held: Q3 2023 490.4k, Q4 2023 490.4k, Q1 2024 490.4k, Q2 2024 710.4k +220.0k +220,000 44.9%
3 ALDEYRA THERAPEUTICS INC COM ALDX ALDX 5,475,516 $18.1m12.21% 12.21% UnchangedShares held: Q3 2023 3.0m, Q4 2023 5.5m, Q1 2024 5.5m, Q2 2024 5.5m
4 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 600,000 $8.4m5.68% 5.68% UnchangedShares held: Q3 2023 600.0k, Q4 2023 600.0k, Q1 2024 600.0k, Q2 2024 600.0k
5 ALTIMMUNE INC COM NEW ALT ALT 1,121,524 $7.5m5.03% 5.03% AddedShares held: Q3 2023 0, Q4 2023 200.0k, Q1 2024 567.2k, Q2 2024 1.1m +554.3k +554,305 97.7%
6 ENTERA BIO LTD SHS ENTX ENTX 3,881,879 $7.1m4.81% 4.81% UnchangedShares held: Q3 2023 2.5m, Q4 2023 3.9m, Q1 2024 3.9m, Q2 2024 3.9m
7 SPDR GOLD TR GOLD SHS GLD GLD 32,000 $6.9m4.64% 4.64% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 32.0k, Q2 2024 32.0k
8 SILVERCREST METALS INC COM SIL SIL 470,000 $3.8m2.58% 2.58% UnchangedShares held: Q3 2023 410.0k, Q4 2023 470.0k, Q1 2024 470.0k, Q2 2024 470.0k
9 KINROSS GOLD CORP COM KGC KGC 440,000 $3.7m2.47% 2.47% UnchangedShares held: Q3 2023 440.0k, Q4 2023 440.0k, Q1 2024 440.0k, Q2 2024 440.0k
10 AGNICO EAGLE MINES LTD COM AEM AEM 55,500 $3.6m2.45% 2.45% UnchangedShares held: Q3 2023 40.0k, Q4 2023 55.5k, Q1 2024 55.5k, Q2 2024 55.5k
11 SEABRIDGE GOLD INC COM COM 246,597 $3.4m2.27% 2.27% UnchangedShares held: Q3 2023 246.6k, Q4 2023 246.6k, Q1 2024 246.6k, Q2 2024 246.6k
12 HOOKIPA PHARMA INC COM COM 5,517,385 $3.3m2.20% 2.20% UnchangedShares held: Q3 2023 5.5m, Q4 2023 5.5m, Q1 2024 5.5m, Q2 2024 5.5m
13 MAG SILVER CORP COM MAG MAG 275,000 $3.2m2.16% 2.16% UnchangedShares held: Q3 2023 160.0k, Q4 2023 105.0k, Q1 2024 275.0k, Q2 2024 275.0k
14 WHEATON PRECIOUS METALS CORP COM WPM WPM 60,000 $3.1m2.12% 2.12% UnchangedShares held: Q3 2023 47.5k, Q4 2023 60.0k, Q1 2024 60.0k, Q2 2024 60.0k
15 FRANCO NEV CORP COM FNV FNV 25,000 $3.0m2.00% 2.00% UnchangedShares held: Q3 2023 14.5k, Q4 2023 0, Q1 2024 25.0k, Q2 2024 25.0k
16 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 200,000 $2.9m1.95% 1.95% UnchangedShares held: Q3 2023 200.0k, Q4 2023 200.0k, Q1 2024 200.0k, Q2 2024 200.0k
17 EQUINOX GOLD CORP COM EQX EQX 550,811 $2.9m1.94% 1.94% UnchangedShares held: Q3 2023 420.9k, Q4 2023 420.9k, Q1 2024 550.8k, Q2 2024 550.8k
18 BOOZ ALLEN HAMILTON HLDG COR CL A BAH BAH 13,000 $2.0m1.35% 1.35% UnchangedShares held: Q3 2023 13.0k, Q4 2023 13.0k, Q1 2024 13.0k, Q2 2024 13.0k
19 GLOBAL X FDS GLOBAL X SILVER SIL SIL 45,175 $1.4m0.95% 0.95% UnchangedShares held: Q3 2023 89.7k, Q4 2023 176.0k, Q1 2024 45.2k, Q2 2024 45.2k
20 OCULAR THERAPEUTIX INC COM OCUL OCUL 200,400 $1.4m0.92% 0.92% UnchangedShares held: Q3 2023 400, Q4 2023 200.4k, Q1 2024 200.4k, Q2 2024 200.4k
21 ISHARES SILVER TR ISHARES SLV SLV 48,500 $1.3m0.87% 0.87% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 48.5k, Q2 2024 48.5k
22 VISA INC COM CL A V V 4,850 $1.3m0.86% 0.86% UnchangedShares held: Q3 2023 4.8k, Q4 2023 4.8k, Q1 2024 4.8k, Q2 2024 4.8k
23 ALAMOS GOLD INC NEW COM CL A AGI AGI 80,000 $1.3m0.85% 0.85% UnchangedShares held: Q3 2023 80.0k, Q4 2023 80.0k, Q1 2024 80.0k, Q2 2024 80.0k
24 PHILIP MORRIS INTL INC COM PM PM 10,000 $1.0m0.68% 0.68% UnchangedShares held: Q3 2023 0, Q4 2023 10.0k, Q1 2024 10.0k, Q2 2024 10.0k
25 ISHARES TR US AER DEF ETF ITA ITA 7,650 $1.0m0.68% 0.68% UnchangedShares held: Q3 2023 0, Q4 2023 7.7k, Q1 2024 7.7k, Q2 2024 7.7k
26 ROYAL GOLD INC COM RGLD RGLD 7,550 $945.0k0.64% 0.64% UnchangedShares held: Q3 2023 7.5k, Q4 2023 7.5k, Q1 2024 7.5k, Q2 2024 7.5k
27 NORTHROP GRUMMAN CORP COM NOC NOC 2,165 $943.8k0.64% 0.64% UnchangedShares held: Q3 2023 2.2k, Q4 2023 2.2k, Q1 2024 2.2k, Q2 2024 2.2k
28 MEREO BIOPHARMA GROUP PLC SPON ADS MREO MREO 260,470 $937.7k0.63% 0.63% UnchangedShares held: Q3 2023 0, Q4 2023 160.5k, Q1 2024 260.5k, Q2 2024 260.5k
29 CVS HEALTH CORP COM CVS CVS 14,500 $856.7k0.58% 0.58% UnchangedShares held: Q3 2023 14.5k, Q4 2023 14.5k, Q1 2024 14.5k, Q2 2024 14.5k
30 DIAGEO PLC SPON ADR NEW DEO DEO 6,750 $851.0k0.57% 0.57% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 6.8k, Q2 2024 6.8k
31 NEW PAC METALS CORP COM NEWP NEWP 485,000 $727.5k0.49% 0.49% UnchangedShares held: Q3 2023 131.7k, Q4 2023 485.0k, Q1 2024 485.0k, Q2 2024 485.0k
32 Orgenesis, Inc. COM COM 634,738 $380.8k0.26% 0.26% UnchangedShares held: Q3 2023 634.7k, Q4 2023 634.7k, Q1 2024 634.7k, Q2 2024 634.7k
33 SKEENA RES LTD NEW COM SKE SKE 38,786 $208.3k0.14% 0.14% UnchangedShares held: Q3 2023 0, Q4 2023 0, Q1 2024 38.8k, Q2 2024 38.8k
34 CARDIOL THERAPEUTICS INC COM CL A CRDL CRDL 100,000 $202.0k0.14% 0.14% NewShares held: Q3 2023 0, Q4 2023 0, Q1 2024 0, Q2 2024 100.0k
35 OPUS GENETICS INC COM IRD IRD 100,000 $153.0k0.10% 0.10% UnchangedShares held: Q3 2023 100.0k, Q4 2023 100.0k, Q1 2024 100.0k, Q2 2024 100.0k

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 ELTX 5.3%≈ $4.7m +0.1 pts 13G 2026-07-08